Skip to content

Screener

Eligibility screening

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

Sponsored by Oruka Therapeutics, Inc.Study detailsClinicalTrials.gov

7 US sites in CA, FL, KY, MD +1

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.